comparemela.com
Latest Breaking News On - Will also lead all activities - Page 1 : comparemela.com
Pharmanovia Enters In-Licensing Agreement With Axsome Therapeutics to Market and Further Develop Sunosi (solriamfetol), a First-In-Class Treatment for Excessive Daytime Sleepiness (EDS) in People With Narcolepsy and Obstructive Sleep Apnoea
The Agreement Covers All Existing Territories in Europe and Any Future Launches Across the Region Pharmanovia Will Also Lead All Activities to Support the Launch of Sunosi (solriamfetol) Across Middle
France
Dennis-riedl
Herriot-tabuteau
James-burt
Alison-dyson
Axsome-therapeutics-inc
Kline
Agreement-covers-all-existing-territories
Any-future-launches-across
Will-also-lead-all-activities
Across-middle-east-north-africa
All-ongoing
vimarsana © 2020. All Rights Reserved.